ALX Oncology to Present at Upcoming Investor Conferences
Globe Newswire•10/11/2026•08:00 ET
0
Key Highlights
- ➤ALX Oncology to present fireside chats at three upcoming investor conferences
- ➤UBS London Healthcare Conference fireside chat scheduled November 17, 2026
- ➤Jefferies London Healthcare Conference fireside chat scheduled November 18, 2026
- ➤Piper Sandler Annual Healthcare Conference fireside chat scheduled December 1, 2026
- ➤ALX2004 Phase 1 dose-escalation trial ongoing in EGFR-expressing solid tumors
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in fireside chats at three upcoming investor conferences.
Format: Fireside Chat and One-on-one Meetings Date: Tuesday, November 17, 2026 Location: London, UK Time of Fireside Chat Presentation: 4:40 PM GMT / 11:40 AM EST Webcast Link: Available here
Get started
Create a free account to read the full story.